Lenvima Lenvatinib 4mg Capsules 10's
Manufacturer: EISAI PHARMACEUTICALS INDIA PVT LTD
Salt: LENVATINIB 4MG
Category: Anti-Cancer, Kidney-Diseases, Liver-Diseases
Price: $154
Availability: In Stock
Lenvima 4mg Capsule is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenvima 4mg Capsule or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenvima 4mg Capsule, as it can impair wound healing and increase the risk of bleeding.
Certain types of advanced thyroid cancer
Advanced Liver cancer
Certain types of kidney cancer
Endometrial cancer
Lenvima Lenvatinib 4mg Capsules 10's
Product Information
What is Lenvima Lenvatinib 4mg Capsules 10's?
Lenvima 4mg Capsule is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenvima 4mg Capsule or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenvima 4mg Capsule, as it can impair wound healing and increase the risk of bleeding.
Indications for Lenvima Lenvatinib 4mg Capsules 10's
Certain types of advanced thyroid cancer
Advanced Liver cancer
Certain types of kidney cancer
Endometrial cancer
Therapeutic Effects of Lenvima Lenvatinib 4mg Capsules 10's
Lenvima Capsule blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumor cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cells’ growth and multiplication.
How to consume Lenvima Lenvatinib 4mg Capsules 10's
Lenvima Capsule is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up for the second dose.
Side Effects of Lenvima Lenvatinib 4mg Capsules 10's
Feeling numb or weak on 1 side of the body
Severe headache
Fever
Confusion
Difficulty speaking
Vision changes
Dizziness
Chest pain or pressure
Pain in arms, jaw, neck, back
Breathing problems
Severe stomach pain
Blood clot formation
Blood in stools or coughing blood
Liver problems
Pain or soreness in the mouth, teeth, or jaw
High or low BP
Loss of appetite
Nausea, vomiting, constipation, diarrhea, or indigestion
Tiredness
Hoarse voice
Leg swelling
Rashes
Pain in joints or muscles
Hair loss
Sleeplessness
Protein in urine, frequent urination
Low potassium, magnesium, and calcium levels in the blood
Dehydration
Skin problems
Gall bladder inflammation
Increase in the values of cholesterol, thyroid-stimulating hormone, digestive enzymes
Delayed wound healing
Drug Interactions
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Lenvima Capsule and reduce effectiveness by causing undesirable side effects.
Storage & Handling
Lenvima Capsule should be stored at room temperature, between 20°C to 25°C (68°F to 77°F).
Protected from light.
Keep it in its original packaging until it is ready to be used.
Keep reach out of the reach of children and pets.
Should be disposed of properly.
Expert Advice
If you are receiving this medication, keep close communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Patients should use effective contraception while taking Lenvima Capsule and for at least two weeks after stopping treatment. Patients should avoid eating grapefruits as they affect the absorption of this. These capsules should not be given to children
You should use sunscreen and wear protective clothing while outdoors to reduce the risk of sunburn or skin damage. Avoid strenuous activities or exercise until you know how this medication is affecting you. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. By being informed and engaged in your treatment, you can help ensure the best possible outcomes and manage any potential risks or complications associated.
Worldwide Shipping & Delivery
We provide specialized tracked delivery for Lenvima Lenvatinib 4mg Capsules 10's to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.
- USA Shipping
- UK Delivery
- UAE & Middle East
- Germany & EU
- Australia
- Canada
Professional Safety Guidelines for Lenvima Lenvatinib 4mg Capsules 10's

Pregnancy
UnsafeLenvima 4mg Capsule is unsafe during pregnancy as it can cause fetal harm. It is recommended to avoid this medication during pregnancy.

BreastFeeding
UnsafeLenvima 4mg Capsule is unsafe during pregnancy as it can cause fetal harm. It is recommended to avoid this medication during pregnancy.

Liver
UnsafeLenvima Capsule is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases. This medication may also increase liver enzymes, which can be a sign of liver damage or inflammation. Patients taking this medication require regular blood tests to monitor liver function monitored.

Lungs
UnsafeLenvima Capsule can cause side effects that affect the lungs, such as cough, shortness of breath, and difficulty breathing. If a person experiences any of these symptoms while taking it, they should notify their healthcare provider right away.

Alcohol
UnsafeIt is recommended to avoid consuming alcohol while taking Lenvima Capsule, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.

Driving
UnsafePatients receiving Lenvima Capsule should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.